196 related articles for article (PubMed ID: 35491652)
1. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.
Hernandez S; Parra ER; Uraoka N; Tang X; Shen Y; Qiao W; Jiang M; Zhang S; Mino B; Lu W; Pandurengan R; Haymaker C; Affolter K; Scaife CL; Yip-Schneider M; Schmidt CM; Firpo MA; Mulvihill SJ; Koay EJ; Wang H; Wistuba II; Maitra A; Solis LM; Sen S
Clin Cancer Res; 2022 May; 28(9):1938-1947. PubMed ID: 35491652
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
3. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.
Semaan A; Bernard V; Wong J; Makino Y; Swartzlander DB; Rajapakshe KI; Lee JJ; Officer A; Schmidt CM; Wu HH; Scaife CL; Affolter KE; Nachmanson D; Firpo MA; Yip-Schneider M; Lowy AM; Harismendy O; Sen S; Maitra A; Jakubek YA; Guerrero PA
Cancer Res Commun; 2023 Oct; 3(10):2062-2073. PubMed ID: 37721516
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.
Bernard V; Semaan A; Huang J; San Lucas FA; Mulu FC; Stephens BM; Guerrero PA; Huang Y; Zhao J; Kamyabi N; Sen S; Scheet PA; Taniguchi CM; Kim MP; Tzeng CW; Katz MH; Singhi AD; Maitra A; Alvarez HA
Clin Cancer Res; 2019 Apr; 25(7):2194-2205. PubMed ID: 30385653
[TBL] [Abstract][Full Text] [Related]
5. Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms.
Gnerlich JL; Ding X; Joyce C; Turner K; Johnson CD; Chen H; Abood GJ; Pappas SG; Aranha GV
Ann Surg Oncol; 2019 Feb; 26(2):628-634. PubMed ID: 30357576
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA sequencing highlights epithelial and microenvironmental heterogeneity in malignant progression of pancreatic ductal adenocarcinoma.
Li J; Wei T; Ma K; Zhang J; Lu J; Zhao J; Huang J; Zeng T; Xie Y; Liang Y; Li X; Zhang Q; Liang T
Cancer Lett; 2024 Mar; 584():216607. PubMed ID: 38246225
[TBL] [Abstract][Full Text] [Related]
7. Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
Eckhoff AM; Brown MC; Landa K; Naqvi I; Holl EK; Boczkowski D; Fletcher A; Rhodin KE; Giang MH; Sullenger B; Beasley GM; Allen PJ; Nair SK
Front Immunol; 2023; 14():1116034. PubMed ID: 37575220
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
[TBL] [Abstract][Full Text] [Related]
9. Long-standing diabetes mellitus increases concomitant pancreatic cancer risk in patients with intraductal papillary mucinous neoplasms.
Yamaguchi A; Tazuma S; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Toyota N; Sudo T; Kuraoka K; Kohno H
BMC Gastroenterol; 2022 Dec; 22(1):529. PubMed ID: 36539713
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
11. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
13. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
14. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
15. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
16. Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential.
Sans M; Makino Y; Min J; Rajapakshe KI; Yip-Schneider M; Schmidt CM; Hurd MW; Burks JK; Gomez JA; Thege FI; Fahrmann JF; Wolff RA; Kim MP; Guerrero PA; Maitra A
Cancer Discov; 2023 Aug; 13(8):1844-1861. PubMed ID: 37285225
[TBL] [Abstract][Full Text] [Related]
17. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study.
Holmberg M; Radkiewicz C; Strömberg C; Öman M; Ghorbani P; Löhr JM; Sparrelid E
Pancreatology; 2023 Jan; 23(1):90-97. PubMed ID: 36522260
[TBL] [Abstract][Full Text] [Related]
18. Quantitative imaging to evaluate malignant potential of IPMNs.
Hanania AN; Bantis LE; Feng Z; Wang H; Tamm EP; Katz MH; Maitra A; Koay EJ
Oncotarget; 2016 Dec; 7(52):85776-85784. PubMed ID: 27588410
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms.
Wood LD; Adsay NV; Basturk O; Brosens LAA; Fukushima N; Hong SM; Kim SJ; Lee JW; Luchini C; Noë M; Pitman MB; Scarpa A; Singhi AD; Tanaka M; Furukawa T
Pancreatology; 2023 Nov; 23(7):878-891. PubMed ID: 37604731
[TBL] [Abstract][Full Text] [Related]
20. Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk.
Overbeek KA; Koopmann BDM; Levink IJM; Tacelli M; Erler NS; Arcidiacono PG; Ausems MGE; Wagner A; van Eijck CH; Groot Koerkamp B; Busch OR; Besselink MG; van der Vlugt M; van Driel LMJW; Fockens P; Vleggaar FP; Poley JW; Capurso G; Cahen DL; Bruno MJ;
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):62-71.e7. PubMed ID: 37031711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
